| DIRECT COMPETITOR COMPARISON | |
| MNOV | Pvt1 | Pvt2 | QCOR | Industry | | Market Cap: | 95.01M | N/A | N/A | 267.56M | 95.05M | | Employees: | 22 | 3001 | N/A | 46 | 63 | | Qtrly Rev Growth (yoy): | N/A | N/A | N/A | -42.80% | 19.70% | | Revenue (ttm): | N/A | 25.00M1 | N/A | 89.43M | 13.84M | | Gross Margin (ttm): | N/A | N/A | N/A | 92.20% | 65.67% | | EBITDA (ttm): | -18.71M | N/A | N/A | 45.77M | -11.86M | | Oper Margins (ttm): | N/A | N/A | N/A | 50.64% | -137.11% | | Net Income (ttm): | -15.87M | N/A | N/A | 34.45M | N/A | | EPS (ttm): | -1.313 | N/A | N/A | 0.513 | -0.31 | | P/E (ttm): | N/A | N/A | N/A | 8.13 | 16.92 | | PEG (5 yr expected): | N/A | N/A | N/A | 0.47 | 1.31 | | P/S (ttm): | N/A | N/A | N/A | 2.99 | 9.80 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 55.07 | 0.00% | 55.74B | 12.01 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 50.25 | 0.00% | 14.53B | 16.82 | | Genzyme Corp. | GENZ | 48.91 | 0.00% | 12.98B | 27.88 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 43.23 | 0.00% | 38.90B | 16.72 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 51.18 | 0.00% | 9.13B | 1044.49 | | Teva Pharmaceutical Industries Limited | TEVA | 53.03 | 0.00% | 46.72B | 48.52 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 38.25 | 0.00% | 4.06B | 19.72 | | King Pharmaceuticals Inc. | KG | 11.87 | 0.00% | 2.95B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.86 | 0.00% | 5.76B | 115.71 | | Pfizer Inc. | PFE | 18.41 | 0.00% | 148.56B | 15.29 | | Johnson & Johnson | JNJ | 64.80 | 0.00% | 178.79B | 14.15 | | GlaxoSmithKline plc | GSK | 42.88 | 0.00% | 108.70B | 13.79 | | Sanofi-Aventis | SNY | 39.21 | 0.00% | 102.38B | N/A | | Novartis AG | NVS | 54.14 | 0.00% | 122.96B | 16.21 |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | RHHBY.PK | 41.83 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 46.15 | 0.00% | 66.92B | 9.27 | | Abbott Laboratories | ABT | 53.88 | 0.00% | 83.34B | 14.60 | | Bristol-Myers Squibb Co. | BMY | 25.81 | 0.00% | 51.13B | 13.35 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|